Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bromodomain inhibitor as adjuvant in cancer immunotherapy

Bromodomain inhibitor as adjuvant in cancer immunotherapy

US Patent 10813939 · Granted Oct 27, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and methods for treating cancer2025
Chromobox protein inhibitors and uses thereof2024
Compositions and methods for selective protein degradation2024
Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of r2024
Compounds and methods for treating cancer2023
Mechanism of resistance to bet bromodomain inhibitors2023
Degradation of protein kinases by conjugation of protein kinase inhibitors with 2023
Combination therapy for cancer using bromodomain and extra-terminal (BET) protei2022
Acetamide thienotriazolodiazepines and uses thereof2022
Cyano thienotriazolodiazepines and uses thereof2022
EZH2 inhibitors and uses thereof2022
Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of r2021